Economic Drivers: How 3D Bioprinting is Reshaping the ADME Tox Market

added blog Health

2026-02-25 11:25:07 -

The intersection of the 3D bioprinting market and the pharmaceutical industry represents one of the most compelling economic narratives in modern healthcare. The cost of bringing a single new drug to market can easily exceed $2 billion, and a significant portion of that capital is wasted on drug candidates that fail during late-stage clinical trials due to unforeseen toxicity or poor metabolic...

0 Comments 0 Shares 552 Views 0 Reviews